ANGEN.E — Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret A Cashflow Statement
0.000.00%
Last trade - 00:00
- TRY3.08bn
- TRY2.73bn
- TRY268.82m
- 67
- 28
- 11
- 24
2018 December 31st | 2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Interim Report | Interim Report | Interim Report | ARS | ARS |
Standards: | — | — | — | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 0.339 | 6.44 | 316 | 443 | 336 |
Depreciation | |||||
Non-Cash Items | 1.26 | 3.89 | 45.9 | -37.6 | -38.9 |
Other Non-Cash Items | |||||
Changes in Working Capital | -0.599 | -6.36 | -132 | -8.43 | -8.61 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 3.16 | 6.69 | 235 | 407 | 311 |
Capital Expenditures | -5.09 | -8.45 | -69.6 | -77.4 | -94.1 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.103 | 0.027 | 2.12 | 10 | -45.9 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -4.99 | -8.42 | -67.5 | -67.4 | -140 |
Financing Cash Flow Items | -1.43 | -1.89 | -59.7 | -2.07 | -0.415 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.69 | 3.16 | -34.9 | -12.8 | -310 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.14 | 1.43 | 133 | 327 | -139 |